Health Condition 1: null- cancer patients undergoing chemotherapy treatment
Conditions
Interventions
None listed
Sponsors
JAMIA HAMDARD
Eligibility
Inclusion criteria
Inclusion criteria: • Patients must have histologically or cytologically confirmed cancer • Patients receiving chemotherapy for the treatment of cancer • Both male and female patients • Patients capable of giving informed consent • Patients willing to participate in the study
Exclusion criteria
Exclusion criteria: • History of major depression • Meet the DSM-IV criteria for a major depressive episode. • Meet criteria for "treatment resistant" depression defined by failure to, respond to, or intolerance of, at least 2 treatments of antidepressants • Active suicidal ideation • History of any major operation in past 6 months excluding surgeries related to cancer treatment • History of any significant cognitive impairment in past • On any psychotropic medications • Presence of any other concurrent illness(Parkinson disorder; Vascular disorders like Hypertension, Stroke; Endocrine disorders like Type II Diabetes Mellitus, Hypothyroidism; AIDS/HIV and rheumatoid arthritis) • Using any concurrent medication like clonidine, methyldopa, isotretinoin, phenobarbital, levetiracetam, phenytoin, triptans and hormonal agents (corticosteroids, oral contraceptives, GnRH agonists and tamoxifen) or whose side effect is depression • Suffered anxiety episodes in past • History of Schizophrenia • Alcoholics • Habit of any substance of abuse • History of significant dementia or intellectual disability • Incompetent for interview • Psychological, familial, sociological, or geographical conditions that do not permit treatment or medical follow-up and / or prohibit compliance with the study protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| prevalence of depression among cancer patientsTimepoint: patients will be assessed initially at the baseline and the consecutively up to two cycles of chemotherapy | — |
Secondary
| Measure | Time frame |
|---|---|
| to evaluate the incidence of depression according to age,gender, education, stage of cancer,type of cancer, types of chemotherapeutic regiments and cycles of chemotherapyTimepoint: baseline and then up to three cycles of chemotherapy | — |
Countries
India
Contacts
Public ContactDr Nidhi
JAMIA HAMDARD
Outcome results
None listed